ProfileGDS4718 / 222125_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 84% 83% 82% 88% 86% 87% 88% 85% 84% 86% 86% 84% 88% 90% 86% 88% 89% 86% 91% 81% 88% 88% 85% 87% 86% 90% 89% 88% 86% 81% 90% 84% 81% 83% 89% 87% 91% 87% 87% 84% 86% 91% 88% 84% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.3659684
GSM549102patient 115, normal, homogenized [OPG study]8.1265683
GSM549104patient 119, normal, homogenized [OPG study]8.1609482
GSM549108patient 138, normal, homogenized [OPG study]8.7814688
GSM549119patient 077, normal, homogenized [OPG study]8.5664886
GSM549133patient 032, cancer, homogenized [OPG study]8.7912487
GSM549139patient 042, cancer, homogenized [OPG study]8.8910588
GSM549099patient 107, normal, homogenized [OPG study]8.3853785
GSM549109patient 139, normal, homogenized [OPG study]8.360384
GSM549110patient 046, normal, homogenized [OPG study]8.5997386
GSM549114patient 063, normal, homogenized [OPG study]8.7076786
GSM549122patient 082, normal, homogenized [OPG study]8.2885384
GSM549134patient 033, cancer, homogenized [OPG study]8.9040788
GSM549136patient 036, cancer, homogenized [OPG study]9.1840790
GSM549140patient 044, cancer, homogenized [OPG study]8.6525886
GSM549111patient 047, normal, homogenized [OPG study]8.9949688
GSM549113patient 057, normal, homogenized [OPG study]9.173489
GSM549132patient 031, cancer, homogenized [OPG study]8.5995986
GSM549137patient 038, cancer, homogenized [OPG study]9.3102691
GSM549142patient 047, cancer, homogenized [OPG study]7.7314481
GSM549100patient 110, normal, homogenized [OPG study]8.8170188
GSM549107patient 135, normal, homogenized [OPG study]8.912688
GSM549115patient 068, normal, homogenized [OPG study]8.6275785
GSM549116patient 072, normal, homogenized [OPG study]8.7832587
GSM549120patient 078, normal, homogenized [OPG study]8.5420486
GSM549131patient 030, cancer, homogenized [OPG study]9.2575990
GSM549118patient 074, normal, homogenized [OPG study]9.0277789
GSM549129patient 027, cancer, homogenized [OPG study]8.7481188
GSM549123patient 088, normal, homogenized [OPG study]8.6542786
GSM549124patient 006, cancer, homogenized [OPG study]7.9370881
GSM549126patient 015, cancer, homogenized [OPG study]9.1700690
GSM549128patient 025, cancer, homogenized [OPG study]8.4533584
GSM549103patient 117, normal, homogenized [OPG study]7.8074481
GSM549117patient 073, normal, homogenized [OPG study]8.2873383
GSM549138patient 041, cancer, homogenized [OPG study]8.9670989
GSM549141patient 045, cancer, homogenized [OPG study]8.823287
GSM549130patient 028, cancer, homogenized [OPG study]9.182391
GSM549101patient 111, normal, homogenized [OPG study]8.7083287
GSM549105patient 128, normal, homogenized [OPG study]8.6566387
GSM549106patient 134, normal, homogenized [OPG study]8.455684
GSM549112patient 048, normal, homogenized [OPG study]8.6313586
GSM549125patient 011, cancer, homogenized [OPG study]9.2437391
GSM549127patient 024, cancer, homogenized [OPG study]8.7897388
GSM549135patient 035, cancer, homogenized [OPG study]8.3927384